Eurofins Scient (OTCMKTS:ERFSF) Stock Price Up 5.4% – Still a Buy?

Shares of Eurofins Scient (OTCMKTS:ERFSF – Get Free Report) rose 5.4% during trading on Wednesday. The stock traded as high as $92.7380 and last traded at $92.7380. Approximately 13 shares traded hands during trading, a decline of 100% from the average daily volume of 3,971 shares. The stock had previously closed at $88.00.

Analyst Ratings Changes

Separately, Sanford C. Bernstein cut shares of Eurofins Scient from an “outperform” rating to a “hold” rating in a research note on Tuesday, September 29th. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold”.

View Our Latest Stock Report on ERFSF

Eurofins Scient Price Performance

The company has a quick ratio of 1.07, a current ratio of 1.13 and a debt-to-equity ratio of 0.80. The firm has a 50 day moving average price of $85.63 and a 200-day moving average price of $79.06.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific SE is a Luxembourg-based international laboratory and testing services company. It provides analytical, inspection and certification services for the pharmaceutical, food, environmental, agricultural, consumer products and healthcare industries.

The company’s services include laboratory testing, product safety and quality analysis, environmental monitoring, pharmaceutical development and validation, genomic testing, clinical diagnostics, and agroscience services. Eurofins also supports companies and public-sector organizations with research, regulatory compliance and quality-control programs.

Founded in 1987 by Gilles Martin, Eurofins has expanded from its original focus on food testing into a broad network of laboratories and specialized testing businesses serving customers in Europe, North America, Asia-Pacific and other international markets.

Featured Stories

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.